1. CD30 and Lymphoma: Pathology in Practice

2. Program Objectives

3. 30 Years of CD30 in Lymphoma

4. Ber-H2 Monoclonal Antibody for CD30 Testing

5. CD30 Expression in Tumors

6. CD30 Expression in DLBCL

7. CD30 Expression in PTCL

8. CD30 Expression in PTCL (cont)

9. CD30 Testing in the Diagnostic Workup

10. CD30 Testing in the Diagnostic Workup: T-Cell Lymphomas

11. CD30 Testing in the Diagnostic Workup: B-Cell Lymphomas

12. Optimizing Fixation

13. Effects of the Length of Fixation

14. Optimizing Antigen Retrieval

15. Ber-H2 Antibody as the Standard

16. Practical Issues in CD30 Testing: Improving Antibody Performance

17. The Need for Standardization in CD30 Testing

18. CD30 IHC Validation Study

19. CD30 IHC Validation Study: Round 2

20. CD30 IHC Validation Study: Round 3

21. CD30 IHC Validation Study: Round 3 (cont)

22. Practical Issues in CD30 Testing: Strategies for Optimizing Results

23. Conclusions

24. Abbreviations

25. Abbreviations (cont)